Procter & Gamble vs Philip Morris International
Procter & Gamble and Philip Morris International are compared on this page to illuminate differences in business models, financial performance, and market context. The analysis stays neutral and accessible, outlining core strategies, revenue drivers, risk factors, and competitive positioning to help readers form an informed view. Educational content, not financial advice.
Procter & Gamble and Philip Morris International are compared on this page to illuminate differences in business models, financial performance, and market context. The analysis stays neutral and acces...
Why It's Moving
PG Delivers Earnings Beat Amid Revenue Miss, Sparking Relief Rally on Steady Guidance
- Beauty category shone as the sole sales volume gainer, fueled by robust self-care demand even as consumers traded down on staples, underscoring PG's premium portfolio strength.
- Core gross margins dipped for a fifth quarter from tariff pressures and supply chain costs, but pricing actions and mix benefits powered the EPS outperformance.
- CEO Shailesh Jejurikar expressed confidence in second-half acceleration, with organic sales guidance held flat to 4% and core EPS at $6.83-$7.09, bolstering faith in navigating macro headwinds.
Philip Morris Faces Valuation Pressure Despite Reduced-Risk Product Growth Driving Top-Line Strength
- PM stock is trading at 468% premium to fair value according to recent analyst assessments, with fair value estimated at $726 while the stock trades near $179, indicating substantial overvaluation risk
- Reduced-risk products continue driving strong top-line growth, yet margin compression and profitability concerns are reinforcing bearish narratives on the company's ability to justify current valuation multiples
- Analyst consensus remains 'Moderate Buy' with some institutions raising stakes, but the gap between current price and intrinsic value estimates suggests limited upside catalysts without significant operational improvements or strategic shifts
PG Delivers Earnings Beat Amid Revenue Miss, Sparking Relief Rally on Steady Guidance
- Beauty category shone as the sole sales volume gainer, fueled by robust self-care demand even as consumers traded down on staples, underscoring PG's premium portfolio strength.
- Core gross margins dipped for a fifth quarter from tariff pressures and supply chain costs, but pricing actions and mix benefits powered the EPS outperformance.
- CEO Shailesh Jejurikar expressed confidence in second-half acceleration, with organic sales guidance held flat to 4% and core EPS at $6.83-$7.09, bolstering faith in navigating macro headwinds.
Philip Morris Faces Valuation Pressure Despite Reduced-Risk Product Growth Driving Top-Line Strength
- PM stock is trading at 468% premium to fair value according to recent analyst assessments, with fair value estimated at $726 while the stock trades near $179, indicating substantial overvaluation risk
- Reduced-risk products continue driving strong top-line growth, yet margin compression and profitability concerns are reinforcing bearish narratives on the company's ability to justify current valuation multiples
- Analyst consensus remains 'Moderate Buy' with some institutions raising stakes, but the gap between current price and intrinsic value estimates suggests limited upside catalysts without significant operational improvements or strategic shifts
Investment Analysis
Pros
- Procter & Gamble has a strong analyst consensus with a 'Buy' rating and an average price target suggesting nearly 20% upside over the next year.
- The company maintains a consistent record of dividend payments, making it attractive for income-focused investors seeking steady returns.
- Procter & Gamble operates globally with a diversified portfolio across multiple consumer product segments, supporting stable revenue streams.
Considerations
- Recent insider selling has been notable, potentially indicating concerns about future company performance among key executives.
- The current price-to-earnings ratio is relatively high, which may suggest the stock is overvalued relative to its earnings potential.
- Stock price volatility and bearish near-term sentiment create some uncertainty, with a trading range and recent lower analyst price targets indicating caution.
Pros
- Philip Morris International has shown strong market cap growth of over 27% in the past year, reflecting robust investor confidence and value creation.
- The company is actively transitioning its product portfolio towards smoke-free alternatives, aligning with evolving regulatory and consumer trends.
- Philip Morris ranks highly in several key performance and risk metrics compared to peers in the tobacco and consumer sectors.
Considerations
- Dependence on tobacco products exposes the company to regulatory risks and shifting public health policies impacting long-term growth.
- Stock price has experienced downward movement recently with some analyst caution, reflecting uncertainties in execution of portfolio transformation.
- The company's cyclicality and exposure to commodity pricing fluctuations could impact profitability under adverse market conditions.
Related Market Insights
The Recession-Proof Portfolio: Why These Stocks Thrive When Markets Crumble
Discover recession-proof stocks that thrive in economic downturns. Build a stable, defensive portfolio with essential goods companies. Invest with Nemo's curated Neme.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
The Recession-Proof Portfolio: Why These Stocks Thrive When Markets Crumble
Discover recession-proof stocks that thrive in economic downturns. Build a stable, defensive portfolio with essential goods companies. Invest with Nemo's curated Neme.
Aimee Silverwood | Financial Analyst
July 25, 2025
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings date is April 24, 2026, for the fiscal year 2026 third quarter results. This follows their historical pattern of releasing quarterly earnings approximately three months after the quarter ends, with Q2 FY2026 reported on January 22, 2026. Investors should anticipate the conference call around 8:30 AM ET on that date, consistent with prior releases.
Philip Morris International (PM) Next Earnings Date
Philip Morris International (PM) is expected to report its next earnings on April 22, 2026, before market open, covering the first quarter ending March 2026. This date aligns with the company's historical pattern of late-April releases for Q1 results, following the most recent Q4 2025 report on February 18, 2026. Investors should monitor for any official announcement confirming the precise timing and conference call details.
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings date is April 24, 2026, for the fiscal year 2026 third quarter results. This follows their historical pattern of releasing quarterly earnings approximately three months after the quarter ends, with Q2 FY2026 reported on January 22, 2026. Investors should anticipate the conference call around 8:30 AM ET on that date, consistent with prior releases.
Philip Morris International (PM) Next Earnings Date
Philip Morris International (PM) is expected to report its next earnings on April 22, 2026, before market open, covering the first quarter ending March 2026. This date aligns with the company's historical pattern of late-April releases for Q1 results, following the most recent Q4 2025 report on February 18, 2026. Investors should monitor for any official announcement confirming the precise timing and conference call details.
Which Baskets Do They Appear In?
Top Stocks for Recessions
These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.
Published: May 3, 2025
Explore BasketWhich Baskets Do They Appear In?
Top Stocks for Recessions
These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.
Published: May 3, 2025
Explore BasketBuy PG or PM in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Procter & Gamble vs British American Tobacco
Procter & Gamble vs British American Tobacco compares business models, financials and market context to help readers decide which company to research further.
Procter & Gamble vs Honeywell
A factual, neutral comparison of Procter & Gamble and Honeywell examining business models, financial metrics, and market context to help readers decide what to research next.
Procter & Gamble vs General Electric
Procter & Gamble vs General Electric compares business models, financial performance, and market context in a neutral overview, highlighting similarities, differences, and research factors.